Estimating the cure proportion of stage IA lung adenocarcinoma: a population-based study

被引：0
|
作者：
Zhixin Huang
Dinghang Chen
Zhinuan Hong
Mingqiang Kang
机构：
[1] Fujian Medical University Union Hospital,Department of Thoracic Surgery
[2] Fujian Medical University,Key Laboratory of Cardio
[3] Fujian Province University,Thoracic Surgery
[4] Fujian Medical University,Key Laboratory of Ministry of Education for Gastrointestinal Cancer
[5] Fujian Medical University,Fujian Key Laboratory of Tumor Microbiology
来源：
BMC Pulmonary Medicine | / 23卷
关键词：
Mixed cure model; Lung adenocarcinoma; Stage IA; Histological subtype; Prognostic analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Indications for sublobar resection of clinical stage IA radiologic pure-solid lung adenocarcinoma
    Hattori, Aritoshi
    Matsunaga, Takeshi
    Takamochi, Kazuya
    Oh, Shiaki
    Suzuki, Kenji
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 154 (03) : 1100 - 1108
  • [42] Integrating IASLC grading and radiomics for predicting postoperative outcomes in stage IA invasive lung adenocarcinoma
    Chen, Yong
    Wu, Jun
    You, Jie
    Gao, Mingjun
    Lu, Shichun
    Sun, Chao
    Shu, Yusheng
    Wang, Xiaolin
    MEDICAL PHYSICS, 2024, 51 (09) : 6513 - 6524
  • [43] Clinical significance of the combination of preoperative SUVmax and CEA in patients with clinical stage IA lung adenocarcinoma
    Hashinokuchi, Asato
    Haratake, Naoki
    Takenaka, Tomoyoshi
    Matsudo, Kyoto
    Nagano, Taichi
    Watanabe, Kenji
    Kosai, Keisuke
    Oku, Yuka
    Ono, Yuki
    Takamori, Shinkichi
    Kohno, Mikihiro
    Baba, Shingo
    Ishigami, Kousei
    Yoshizumi, Tomoharu
    THORACIC CANCER, 2022, 13 (18) : 2624 - 2632
  • [44] Lymph node metastasis risk factors in clinical stage IA3 lung adenocarcinoma
    Zheng, Yuanliang
    Ju, Sheng
    Huang, Risheng
    Zhao, Jun
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (01) : 34 - 38
  • [45] Impact of a Ground-glass Opacity Component on c-Stage IA Lung Adenocarcinoma
    Li, Ming
    Xi, Junjie
    Sui, Qihai
    Kuroda, Hiroaki
    Hamanaka, Kazutoshi
    Bongiolatti, Stefano
    Hong, Goohyeon
    Zhan, Cheng
    Feng, Mingxiang
    Wang, Qun
    Tan, Lijie
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2023, 35 (04) : 783 - 795
  • [46] High tumor mutation burden predicts favorable outcome among patients with aggressive histological subtypes of lung adenocarcinoma: A population-based single-institution study
    Talvitie, Eva-Maria
    Vilhonen, Heikki
    Kurki, Samu
    Karlsson, Antti
    Orte, Katri
    Almangush, Alhadi
    Mohamed, Hesham
    Liljeroos, Lassi
    Singh, Yajuvinder
    Leivo, Ilmo
    Laitinen, Tarja
    Kallajoki, Markku
    Taimen, Pekka
    NEOPLASIA, 2020, 22 (09): : 333 - 342
  • [47] Highly proliferating cancer cells function as novel prognostic biomarkers for lung adenocarcinoma with particular usefulness for stage IA risk stratification
    Xiong, Yanlu
    Ma, Yongfu
    Lei, Jie
    Zhu, Jianfei
    Xie, Nianlin
    Tian, Feng
    Lu, Qiang
    Wen, Miaomiao
    Zheng, Qian
    Han, Yong
    Jiang, Tao
    Liu, Yang
    BMC CANCER, 2025, 25 (01)
  • [48] Predictors of upstage and treatment strategies for stage IA lung cancers after sublobar resection for adenocarcinoma in situ and minimally invasive adenocarcinoma
    Su, Hang
    Gu, Chang
    She, Yunlang
    Xu, Long
    Yang, Ping
    Xie, Huikang
    Zhao, Shengnan
    Wu, Chunyan
    Xie, Dong
    Chen, Chang
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (01) : 32 - +
  • [49] Tumor Differentiation and EGFR Mutation Associated with Disease-Free Survival in Stage IA Lung Adenocarcinoma Patients with Curative Surgery
    Yang, Lu
    Pang, Chong
    Xu, Fei
    Yang, Guangian
    Xu, Haiyan
    Wang, Changli
    Wang, Yan
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 12549 - 12556
  • [50] CT morphological features and histogram parameters to predict micropapillary or solid components in stage IA lung adenocarcinoma
    Chen, Qin
    Lin, Kaihe
    Zhang, Baoteng
    Jiang, Youqin
    Wu, Suying
    Lin, Jiajun
    FRONTIERS IN ONCOLOGY, 2024, 14
12345